PHARMA TECHNOLOGY A/S: Financial statements 2022
CVR: 20826746
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMA TECHNOLOGY A/S (CVR 20826746) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 20,334,078 and a net result of DKK 7,100,737 compared with DKK 7,621,354 the year before. That is an increase of 6.2% compared with the year before. Equity in the 2022 report amounted to DKK 7,600,737. The solvency ratio was 36.3%. The company had 11 employees in the financial year.
- Gross Profit
- DKK 20,334,078
- Profit/Loss
- DKK 7,100,737
- Equity
- DKK 7,600,737
- Total Assets
- DKK 20,962,373
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 20.3 mio. | 7.1 mio. | 7.6 mio. | 11 |
| 2021 | - | 19.2 mio. | 7.6 mio. | 8.1 mio. | 11 |
| 2020 | - | 13.9 mio. | 6.3 mio. | 6.8 mio. | 8 |
| 2019 | - | 9.3 mio. | 3.7 mio. | 4.2 mio. | 6 |
| 2018 | - | 10.9 mio. | 3.5 mio. | 4 mio. | - |
Official annual report
Keep an eye on PHARMA TECHNOLOGY A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMA TECHNOLOGY A/S has published its annual report for 2021. Gross profit came to DKK 19,151,464, and the net result was DKK 7,621,354.
About PHARMA TECHNOLOGY A/S
PHARMA TECHNOLOGY A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1998. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Flemming Sten Pedersen. The board consists of Flemming Sten Pedersen, Inge Holsted Hansen and Svenn Ryberg Hansen. The company is owned by FPIH HOLDING ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 48,337,049 and a net result of DKK 12,305,927 compared with DKK 9,046,574 the year before. Equity in the 2025 report amounted to DKK 12,805,927.